Human CXCL13/BLC/BCA-1 DuoSet ELISA DY801 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemHuman CXCL13/BLC/BCA-1 DuoSet ELISA
CompanyR&D Systems, a Bio-Techne Brand
Price $890.00Supplier Page View Company Product Page
Catalog NumberDY801
Quantity1 Kit (for 15 Plates)
ApplicationsELISA
Detection Range15.60 - 1000 pg/mL
ReactivityHuman
Detection TargetCXCL13/BLC/BCA-1
StorageStore the unopened product at 2 - 8 °C. Do not use past expiration date
NCBI Full Gene NameC-X-C motif chemokine ligand 13
NCBI Gene AliasesANGIE, ANGIE2, BCA-1, BCA1, BLC, BLR1L, SCYB13

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) SARS-CoV-2 spike protein expression drives post-acute coagulopathyJournal of VirologyFebruary 17, 2026Chih-Feng Tien, En-Ju Lin, Wei-Hsiang Tsai, Wan-Ting Tsai, Ming-Yu Chen, Yu-Siang Su, Han-Chieh Wu, Yueh-Tzu Chiu, Wan-Ju Tung, Yi-Ping Kuo, et al.Mouse CXCL13/BLC/BCA-1 DuoSet ELISA (DY470), Human IGFBP-1 ELISA (DY871), and Human CXCL13/BLC/BCA-1 ELISA (DY801) (R&D Systems, Minneapolis, MN, USA), according to the manufacturer’s instructions. The anti-S specific

(2) Dynamics of Cytokines and Chemokines During the Peripartum Period in People Living With Human Immunodeficiency VirusAm J Reprod ImmunolAugust 22, 2025Jacqueline Corry, Natalia Zotova, Martine Tabala, Christina K. Cotrone, Fidéle Lumande Kasindi, Bienvenu Lebwaze Massamba, Pelagie Babakazo, Namal P. M. Liyanage, Nicholas T. Funderburg, Marcel Yotebieng, et al.Qognit Inc.). Seven immune factors were individually measured by duoset ELISA (R&D Systems): CXCL13 (DY801), IL‐4 (DY204), IFN‐λ‐1(DY7246), soluble monocyte differentiation antigen CD14 (sCD14, DY383), soluble

(3) Ex Vivo Overactivation of Lymphocyte Subsets in Fibrotic Hypersensitivity Pneumonitis Is Blunted by a Sphingosine-1-Phosphate Receptor LigandInternational journal of molecular sciencesMarch 29, 2025Courtemanche O, Huppé CA, Blais-Lecours P, Maranda C, Morissette MC, Blanchet MR, Dion G, Marsolais D.

(4) Tumor-specific antibodies elicited by engineered bacteria promote bladder cancer immunotherapybioRxiv : the preprint server for biologyOctober 29, 2024Rouanne M, Chen N, Mariuzza DL, Li F, de Los Santos-Alexis K, Savage TM, Vincent RL, Mendelsohn CL, Danino T, Arpaia N.

(5) Modeling memory B cell responses in a lymphoid organ-chip to evaluate mRNA vaccine boostingJournal of Experimental MedicineOctober 7, 2024Raphaël Jeger-Madiot, Delphine Planas, Isabelle Staropoli, Hippolyte Debarnot, Jérôme Kervevan, Héloïse Mary, Camilla Collina, Barbara F. Fonseca, Rémy Robinot, Stacy Gellenoncourt, et al.production The chemokine CXCL13 was measured in LO chip effluent using a human CXCL13 ELISA assay (#DY801; Quantikine, R&D Systems) following the manufacturer’s instructions. S-Flow antibody assay IgG and

(6) Interferon subverts an AHR-JUN axis to promote CXCL13(+) T cells in lupusNatureJuly 1, 2024Law C, Wacleche VS, Cao Y, Pillai A, Sowerby J, Hancock B, Horisberger A, Bracero S, Skidanova V, Li Z, et al.

(7) Soluble CD27 is an intrathecal biomarker of T-cell-mediated lesion activity in multiple sclerosisJournal of neuroinflammationApril 12, 2024Cencioni MT, Magliozzi R, Palmisano I, Suwan K, Mensi A, Fuentes-Font L, Villar LM, Fernández-Velasco JI, Migallón NV, Costa-Frossard L, et al.

(8) Dietary Polyphenols Decrease Chemokine Release by Human Primary Astrocytes Responding to Pro-Inflammatory CytokinesPharmaceuticsSeptember 7, 2023Grabarczyk M, Ksiazek-Winiarek D, Glabinski A, Szpakowski P.

(9) Novel Fas-TNFR chimeras that prevent Fas ligand-mediated kill and signal synergistically to enhance CAR T cell efficacyMolecular therapy. Nucleic acidsJune 13, 2023McKenzie C, El-Kholy M, Parekh F, Robson M, Lamb K, Allen C, Sillibourne J, Cordoba S, Thomas S, Pule M.(BioLegend, 431804), CCL1 (R&D Systems, DY272), CXCL10 (R&D Systems, DY266), and CXCL13 (R&D Systems, DY801) according to the manufacturer’s instructions using a Multiskan FC microplate photometer (Thermo Scientific). Detection

(10) PD-1(high)CXCR5(-)CD4(+) peripheral helper T cells promote CXCR3(+) plasmablasts in human acute viral infectionCell reportsJanuary 31, 2023Asashima H, Mohanty S, Comi M, Ruff WE, Hoehn KB, Wong P, Klein J, Lucas C, Cohen I, Coffey S, et al.

(11) Association between the expression of toll-like receptors, cytokines, and homeostatic chemokines in SARS-CoV-2 infection and COVID-19 severityHeliyonJanuary 1, 2023Alturaiki W, Alkadi H, Alamri S, Awadalla ME, Alfaez A, Mubarak A, Alanazi MA, Alenzi FQ, Flanagan BF, Alosaimi B.were quantified using ELISA kits (DuoSet ELISA DY814-05, DY124-05, DY884B, DY366, DY361, DY350, and DY801, respectively; R&D Systems, Minneapolis, MN, USA) according to the manufacturer's instructions. The

(12) Human Primary Astrocytes Differently Respond to Pro- and Anti-Inflammatory StimuliBiomedicinesJuly 22, 2022Szpakowski P, Ksiazek-Winiarek D, Turniak-Kusy M, Pacan I, Glabinski A.

(13) Ectopic Lymphoid Follicle Formation and Human Seasonal Influenza Vaccination Responses Recapitulated in an Organ-on-a-ChipAdvanced science (Weinheim, Baden-Wurttemberg, Germany)May 1, 2022Goyal G, Prabhala P, Mahajan G, Bausk B, Gilboa T, Xie L, Zhai Y, Lazarovits R, Mansour A, Kim MS, et al.(#501302), or IL‐10 (#50680) and from R&D Systems against IL‐2 (#MAB602), GM‐CSF (#MAB615), or CXCL13 (#DY801). Secondary antibodies used in these studies against IL 10 (#501501) and IL‐7 (#506601) were from Biolegend,

(14) CXCL13 Is an Indicator of Germinal Center Activity and Alloantibody Formation Following TransplantationTransplantation directDecember 1, 2021Crichton ES, Zeng S, La Muraglia GM 2nd, Badell IR.antibody were used. The human CXCL13/BLC/BCA-1 Quantikine or DuoSet ELISA kit (R&D Systems DCX130 or DY801) was used to test human samples. Antibody Assessments For DSA measurements, flow cytometric crossmatch

(15) Cerebrospinal fluid cytokine levels are associated with macrophage infiltration into tumor tissues of glioma patientsBMC cancerOctober 15, 2021Kemmerer CL, Schittenhelm J, Dubois E, Neumann L, Häsler LM, Lambert M, Renovanz M, Kaeser SA, Tabatabai G, Ziemann U, et al.

(16) Plasma markers in pulmonary hypertension subgroups correlate with patient survivalRespiratory researchMay 4, 2021Koudstaal T, van Uden D, van Hulst JAC, Heukels P, Bergen IM, Geenen LW, Baggen VJM, van den Bosch AE, van den Toorn LM, Chandoesing PP, et al.

(17) Cerebrospinal Fluid Biomarkers of Myeloid and Glial Cell Activation Are Correlated With Multiple Sclerosis Lesional Inflammatory ActivityFrontiers in neuroscienceJanuary 1, 2021Masvekar R, Phillips J, Komori M, Wu T, Bielekova B.,R&D Systems (MAB1295 and BAF1295),1 μg/ml and 250 ng/ml,125 ng/ml CXCL13,Homebrew MSD-ECL,R&D Systems (DY801),1 μg/ml and 100 ng/ml,17.4 pg/ml CD27,Homebrew MSD-ECL,Sanquin (M1960),1:100 and 1:100,0.4 U/ml CD14,Homebrew

(18) Activin A programs the differentiation of human TFH cellsNature immunologyAugust 1, 2016Locci M, Wu JE, Arumemi F, Mikulski Z, Dahlberg C, Miller AT, Crotty S.

(19) TGF-β induces the differentiation of human CXCL13-producing CD4(+) T cellsEuropean journal of immunologyFebruary 1, 2016Kobayashi S, Watanabe T, Suzuki R, Furu M, Ito H, Ito J, Matsuda S, Yoshitomi H.

(20) CNS vasculitis in a patient with MS on daclizumab monotherapyNeurologyJanuary 29, 2013Joan Ohayon, Unsong Oh, Nancy Richert, Jayne Martin, Alexander Vortmeyer, Henry McFarland, Bibiana Bielekovainterferon-g as described.2 CXCL13 was measured by ELISA (R&D Systems, Minneapolis, MN; Catalogue number DY801). Supplemental data at www.neurology.org Supplemental Data Standard protocol approvals, registrations,

Be the First to Write a Review!

Human CXCL13/BLC/BCA-1 DuoSet ELISA

Human CXCL13/BLC/BCA-1 DuoSet ELISA from R&D Systems, a Bio-Techne Brand

R&D Systems, a Bio-Techne Brand

Citations (26)

Reviews

Human CXCL13/BLC/BCA-1 DuoSet ELISA from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map